Adams and Colin were back on the road this month, visiting with partners at Prevention Point in Pittsburgh, Pennsylvania. The two spent time with 27 people who use drugs, learning more about naloxone use and overdose response strategies, xylazine trends, and a potential mystery substance some are calling "trippy dope," which seems to cause mild hallucinations. Adams and Colin will take a break from traveling for the holidays before resuming data collection in Sacramento in the new year.